Among the different subgroups, PD‐L1 was positive in 37.8% of SCC cases (28 out of 74) versus in 28.6% (2 out of 7) of adenosquamous carcinomas vs. 16.7% (2 out of 12) of endocervical adenocarcinomas. This evidence concerns the gene CD274 and adenosquamous carcinoma.